Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Related Posts
The Gloves Are Off in the Fight for Your Right to Repair
This year, the right-to-repair movement got a boost from—surprisingly—big tech, tariffs, and economic downturn. But the companies controlling who fixes their stuff aren’t giving up that power willingly.
The Curling Controversy at the Winter Olympics Isn’t What You Think
After Swedish curler Oskar Eriksson accused Canadian vice-skip Marc Kennedy of cheating last week, everyone has become an expert in curling rules. They’re missing the point.
3 Best Hall Effect Keyboards for Gamers and Serious Typists (2025)
Ascend from your mechanical keyboard to magnetically powered Hall effect switches.

